2/24
07:00 am
brkr
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
Low
Report
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
2/23
07:00 am
brkr
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Medium
Report
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
2/23
07:00 am
brkr
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
Medium
Report
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
2/19
08:00 am
brkr
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players [Yahoo! Finance]
Low
Report
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players [Yahoo! Finance]
2/13
11:44 am
brkr
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at TD Cowen from $53.00 to $43.00. They now have a "hold" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at TD Cowen from $53.00 to $43.00. They now have a "hold" rating on the stock.
2/13
10:57 am
brkr
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/13
10:16 am
brkr
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
2/13
08:05 am
brkr
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
2/13
07:17 am
brkr
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/12
04:23 pm
brkr
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... [Yahoo! Finance]
Medium
Report
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... [Yahoo! Finance]
2/12
04:10 pm
brkr
Bruker (NASDAQ:BRKR) was given a new $50.00 price target on by analysts at Jefferies Financial Group Inc..
Low
Report
Bruker (NASDAQ:BRKR) was given a new $50.00 price target on by analysts at Jefferies Financial Group Inc..
2/12
01:37 pm
brkr
Bruker Corporation (BRKR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Bruker Corporation (BRKR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/12
12:53 pm
brkr
Bruker Corporation Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Bruker Corporation Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/12
07:00 am
brkr
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
2/9
07:00 am
brkr
Chemspeed and SciY Announce Self-Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
Low
Report
Chemspeed and SciY Announce Self-Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
2/9
07:00 am
brkr
Bruker Introduces iNTApharma™, a Label-Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
Low
Report
Bruker Introduces iNTApharma™, a Label-Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
2/5
04:05 pm
brkr
Bruker Announces Quarterly Preferred Stock Dividend
Low
Report
Bruker Announces Quarterly Preferred Stock Dividend
2/5
08:00 am
brkr
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
Low
Report
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
1/31
09:16 pm
brkr
Guggenheim Raises Price Target for Bruker Corporation (BRKR) [Yahoo! Finance]
Low
Report
Guggenheim Raises Price Target for Bruker Corporation (BRKR) [Yahoo! Finance]
1/26
10:59 am
brkr
Bruker (NASDAQ:BRKR) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Bruker (NASDAQ:BRKR) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/19
05:06 pm
brkr
Bruker Corporation (BRKR): A Bull Case Theory [Yahoo! Finance]
Low
Report
Bruker Corporation (BRKR): A Bull Case Theory [Yahoo! Finance]
1/19
12:19 pm
brkr
Where The Department of Energy Is Investing [zero hedge]
Low
Report
Where The Department of Energy Is Investing [zero hedge]
1/16
06:04 am
brkr
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
1/9
07:03 pm
brkr
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI [Yahoo! Finance]
Low
Report
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI [Yahoo! Finance]
1/9
07:00 am
brkr
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI
Medium
Report
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI